Virgolini IJ - Search Results

1

Comparison of [⁶⁸Ga]Ga-PSMA-11 PET/CT with [¹⁸F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.

Uprimny C, Svirydenka A, Fritz J, Kroiss AS, Nilica B, Decristoforo C, Haubner R, von Guggenberg E, Buxbaum S, Horninger W, Virgolini IJ. Uprimny C, et al. Among authors: virgolini ij. Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1873-1883. doi: 10.1007/s00259-018-4048-6. Epub 2018 May 16. Eur J Nucl Med Mol Imaging. 2018. PMID: 29766246

2

Nuclear medicine and atherosclerosis.

Sinzinger H, Virgolini I. Sinzinger H, et al. Eur J Nucl Med. 1990;17(3-4):160-78. doi: 10.1007/BF00811446. Eur J Nucl Med. 1990. PMID: 2279498 Review.

3

In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.

Virgolini I, Angelberger P, Li S, Yang Q, Kurtaran A, Raderer M, Neuhold N, Kaserer K, Leimer M, Peck-Radosavljevic M, Scheithauer W, Niederle B, Eichler HG, Valent P. Virgolini I, et al. Eur J Nucl Med. 1996 Oct;23(10):1388-99. doi: 10.1007/BF01367597. Eur J Nucl Med. 1996. PMID: 8781146

4

Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.

Raderer M, Becherer A, Kurtaran A, Angelberger P, Li S, Leimer M, Weinlaender G, Kornek G, Kletter K, Scheithauer W, Virgolini I. Raderer M, et al. J Nucl Med. 1996 Sep;37(9):1480-7. J Nucl Med. 1996. PMID: 8790198 Free article. Clinical Trial.

5

Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphy.

Kurtaran A, Pfreitfellner J, Schaffarich P, Smith-Jones P, Niederle B, Raderer M, Virgolini I, Bergmann H, Havlik E. Kurtaran A, et al. Eur J Nucl Med. 1997 Oct;24(10):1298-300. doi: 10.1007/s002590050155. Eur J Nucl Med. 1997. PMID: 9323272

6

Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin.

Kurtaran A, Müller C, Novacek G, Kaserer K, Mentes M, Raderer M, Pidlich J, Eibenberger K, Angelberger P, Virgolini I. Kurtaran A, et al. J Nucl Med. 1997 Dec;38(12):1912-5. J Nucl Med. 1997. PMID: 9430468 Free article.

7

Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma.

Leimer M, Kurtaran A, Smith-Jones P, Raderer M, Havlik E, Angelberger P, Vorbeck F, Niederle B, Herold C, Virgolini I. Leimer M, et al. J Nucl Med. 1998 Dec;39(12):2090-4. J Nucl Med. 1998. PMID: 9867148 Free article.

8

111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.

Traub T, Petkov V, Ofluoglu S, Pangerl T, Raderer M, Fueger BJ, Schima W, Kurtaran A, Dudczak R, Virgolini I. Traub T, et al. J Nucl Med. 2001 Sep;42(9):1309-15. J Nucl Med. 2001. PMID: 11535718 Free article.

9

111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.

Li S, Kurtaran A, Li M, Traub-Weidinger T, Kienast O, Schima W, Angelberger P, Virgolini I, Raderer M, Dudczak R. Li S, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1087-95. doi: 10.1007/s00259-003-1206-1. Epub 2003 May 24. Eur J Nucl Med Mol Imaging. 2003. PMID: 12768334 Clinical Trial.

10

18FDG-PET for monitoring disease activity in an HIV-1 positive patient with disseminated chronic osteomyelitic brucellosis due to Brucella melitensis.

Zaknun JJ, Zangerle R, Gabriel M, Virgolini I. Zaknun JJ, et al. Eur J Nucl Med Mol Imaging. 2005 May;32(5):630. doi: 10.1007/s00259-004-1699-2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15549294 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page